Table 2.
Inhaled medication used by COPD patients (N=257)
| n (%) | |
|---|---|
| ICS | 6 (2.4) |
| LABA | 60 (23.5) |
| LAMA | 2 (0.8) |
| LABA + ICS | 141 (55.3) |
| LAMA + ICS | 2 (0.8) |
| LAMA + LABA | 4 (1.6) |
| LAMA + LABA + ICS | 14 (5.5) |
| SABA | 2 (0.8) |
| SABA + ICS | 3 (1.2) |
| SABA + LAMA + LABA | 1 (0.4) |
| SABA + LAMA + LABA + ICS | 6 (2.4) |
| SAMA + SABA | 2 (0.8) |
| SAMA + SABA + ICS | 8 (3.1) |
| All | 2 (0.8) |
| None | 2 (0.8) |
Abbreviations: ICS, inhaled corticosteroid; LABA, long-acting beta agonist; LAMA, long-acting muscarinic antagonist; SABA, short-acting beta agonist; SAMA, short-acting muscarinic antagonist.